(Q35601575)

9 August 2017

1 reference

title

Bringing order to the glutamate chaos in schizophrenia (English)

1 reference

9 August 2017

0 references

1

Bita Moghaddam

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

40

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

881-884

1 reference

Association and linkage analyses of RGS4 polymorphisms in schizophrenia

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Ionotropic glutamate receptors as therapeutic targets in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Genes for schizophrenia? Recent findings and their pathophysiological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Medicine. What are the right targets for psychopharmacology?

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Effects of ketamine in normal and schizophrenic volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

N‐methyl‐d‐aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia: TDT and case‐control analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

RGS4 inhibits signaling by group I metabotropic glutamate receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Neuregulin 1 and susceptibility to schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0896-6273%2803%2900757-8

7 January 2021

10.1016/S0896-6273(03)00757-8

Identifiers

DOI

1 reference

9 August 2017

1 reference